CDC Alerts Providers to Respiratory Syncytial Virus (RSV) Vaccine Administration Errors in Young Children and Pregnant Patients

Published: 01/22/2024

Sources:
  • Centers for Disease Control and Prevention
Relevant To:
  • Urgent Care,
  • Medical Office,
  • Critical Access Hospitals,
  • Hospitals,
  • Ambulatory Care,
  • Pharmacy,
  • Rural Health Clinics

Since approval of RSV vaccines and the monoclonal antibody nirsevimab, the Centers for Disease Control and Prevention (CDC) and the Food and Drug Administration (FDA) have received reports of the Pfizer (Abrsyvo) or GSK (Arexvy) RSV vaccines being administered in error to young children.

CDC and FDA have also received reports of the GSK RSV vaccine (Arexvy) being administered in error to pregnant patients.

According to the CDC, as of January 17, 2024, the number of reports received by VAER…

Sign Up for Free Trial